Therapies for Children With Autism Spectrum Disorders

Evidence Table. Therapies for children with ASD
Study
Description Intervention
Inclusion/Exclusion
Criteria/Population
C-368
Baseline
Measures Outcomes
entry and 12
months (both r =
0.78) and
between IQ at
study entry and IQ
at 12 months (r =
0.93).
VABS composite
scores at study
entry and 12
months were
significantly
correlated (r =
0.91), but not with
early VABS
composite score.
Change in IQ from
early measure to
study entry was
predicted only by
age at start of
behavioral
treatment (r = -
0.39, P = 0.04).
There was no
effect of group
level of consultants
on changes
in IQ and VABS
scales from study
entry to 12
months.
Comments: *There were 12 children in both G1a and G1c and 9 children in both G1a and G1b. Means and variances were
not significantly different between G1a and G1b, so the authors considered these values as representative for the overall group
of participants at baseline.
**Among 6 who had ceased to receiving EIBI before follow-up, 5 were receiving special needs school education and 1 had no
school placement.